Serum lactate dehydrogenase predicts prognosis and correlates with systemic inflammatory response in patients with advanced pancreatic cancer after gemcitabine-based chemotherapy

Genomic analyses identify molecular subtypes of pancreatic cancer

(2016) Peter Bailey et al.   NATURE

Glypican-1 identifies cancer exosomes and detects early pancreatic cancer

(2015) Sonia A. Melo et al.   NATURE

Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer

(2015) Q. Qi et al.   PANCREATOLOGY

Pancreatic Adenocarcinoma

(2015) David P. Ryan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy

(2014) Faruk Tas et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients

(2014) Ye Chen et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

The Clinical Utility of Biomarkers in the Management of Pancreatic Adenocarcinoma

(2014) Khalid A. Jazieh et al.   SEMINARS IN RADIATION ONCOLOGY

Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia

(2013) M Maftouh et al.   BRITISH JOURNAL OF CANCER

Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy

(2013) Michael Haas et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9

(2013) Umashankar K. Ballehaninna et al.   TUMOR BIOLOGY

Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients

(2012) M Scartozzi et al.   BRITISH JOURNAL OF CANCER

Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis

(2012) B Weide et al.   BRITISH JOURNAL OF CANCER

Serum Lactate Dehydrogenase Is Prognostic for Survival in Patients with Bone Metastases from Breast Cancer: A Retrospective Analysis in Bisphosphonate-Treated Patients

(2012) J. E. Brown et al.   CLINICAL CANCER RESEARCH

MS analysis reveals O-methylation of L-lactate dehydrogenase from pancreatic ductal adenocarcinoma cells

(2012) Weidong Zhou et al.   ELECTROPHORESIS

Serum Lactate Dehydrogenase Predicts for Overall Survival Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Inhibition of Mammalian Target of Rapamycin

(2012) Andrew J. Armstrong et al.   JOURNAL OF CLINICAL ONCOLOGY

Advanced Stage, Increased Lactate Dehydrogenase, and Primary Site, but Not Adolescent Age (≥ 15 Years), Are Associated With an Increased Risk of Treatment Failure in Children and Adolescents With Mature B-Cell Non-Hodgkin's Lymphoma: Results of the FAB LMB 96 Study

(2012) Mitchell S. Cairo et al.   JOURNAL OF CLINICAL ONCOLOGY

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

(2012) Andrew V. Biankin et al.   NATURE

The Role of LDH Serum Levels in Predicting Global Outcome in HCC Patients Undergoing TACE: Implications for Clinical Management

(2012) Mario Scartozzi et al.   PLoS One

Lactate Dehydrogenase B Is Critical for Hyperactive mTOR-Mediated Tumorigenesis

(2011) X. Zha et al.   CANCER RESEARCH

Prognostic and Predictive Role of Lactate Dehydrogenase 5 Expression in Colorectal Cancer Patients Treated with PTK787/ZK 222584 (Vatalanib) Antiangiogenic Therapy

(2011) M. I. Koukourakis et al.   CLINICAL CANCER RESEARCH

Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma

(2011) Friederike Egberts et al.   EUROPEAN JOURNAL OF CANCER

Elevated LDH predicts poor outcome of recurrent germ cell tumours treated with dose dense chemotherapy

(2010) Marco Gerlinger et al.   EUROPEAN JOURNAL OF CANCER

Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression

(2010) A. Le et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA